IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes Post author:Sam Post published:November 9, 2017 Post category:BioPharma ImmunoMolecular Therapeputics officially launched yesterday. Source: BioSpace You Might Also Like AbbVie's $175 Million Gamble Pays Off as Ablynx RA Drug Meets Goal in Phase II Study July 8, 2016 World's Smartest Billionaire Upped Position in This Bay Area Biotech March 14, 2017 Booming Abeona Plans to Hire Dozens of New Employees in Expansion November 9, 2017
